drugset / Trial / NCT01992042
Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
This research study provides a novel opportunity to examine the intra-prostatic tumour inhibitory effects of statins in men with prostate cancer undergoing surgery.
Timeline
- Start
- 2014-02
- Primary completion
- 2016-10
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluvastatin | Other / unclassified | 40 mg | — |
| Background | Pimonidazole | Diagnostic / imaging agent | — | — |